Related references
Note: Only part of the references are listed.Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Barton F. Haynes et al.
NATURE REVIEWS IMMUNOLOGY (2023)
HIV-1 infections with multiple founders associate with the development of neutralization breadth
Eric Lewitus et al.
PLOS PATHOGENS (2022)
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
Peng Zhang et al.
NATURE MEDICINE (2021)
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
L. Corey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults
Glenda E. Gray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patients
Rute Marcelino et al.
SCIENTIFIC REPORTS (2021)
Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth
Deniz Cizmeci et al.
ELIFE (2021)
Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study
Benn Sartorius et al.
Lancet HIV (2021)
Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic
David A. Spencer et al.
FRONTIERS IN PUBLIC HEALTH (2021)
Factors Influencing HIV Drug Resistance among Pregnant Women in Luanda, Angola: Findings from a Cross-Sectional Study
Cruz S. Sebastiao et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2021)
Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention
Kathryn E. Stephenson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing Antibodies
Rita Calado et al.
VACCINES (2020)
Early ART in Acute HIV-1 Infection: Impact on the B-Cell Compartment
Robert Badura et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Envelope characteristics in individuals who developed neutralizing antibodies targeting different epitopes in HIV-1 subtype C infection
Bongiwe Ndlovu et al.
VIROLOGY (2020)
Broadly neutralizing plasma antibodies effective against autologous circulating viruses in infants with multivariant HIV-1 infection
Nitesh Mishra et al.
NATURE COMMUNICATIONS (2020)
An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes
Adam S. Dingens et al.
IMMUNITY (2019)
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
Till Schoofs et al.
IMMUNITY (2019)
The HIV-1 Envelope Glycoprotein C3/V4 Region Defines a Prevalent Neutralization Epitope following Immunization
Lin Lei et al.
CELL REPORTS (2019)
Neutralizing antibodies for HIV-1 prevention
Boris Julg et al.
CURRENT OPINION IN HIV AND AIDS (2019)
The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes
Hongjun Bai et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Impact of HIV-1 Diversity on Its Sensitivity to Neutralization
Karl Stefic et al.
VACCINES (2019)
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design (vol 25, pg 59, 2019)
Christine A. Bricault et al.
CELL HOST & MICROBE (2019)
Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies
Batsirai M. Mabvakure et al.
JOURNAL OF VIROLOGY (2019)
An HIV-1 Broadly Neutralizing Antibody from a Clade C-Infected Pediatric Elite Neutralizer Potently Neutralizes the Contemporaneous and Autologous Evolving Viruses
Sanjeev Kumar et al.
JOURNAL OF VIROLOGY (2019)
The Neutralizing Antibody Response to he HIV-1 Env Protein
Penny L. Moore
CURRENT HIV RESEARCH (2018)
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
Peter D. Kwong et al.
IMMUNITY (2018)
Datamonkey 2.0: A Modern Web Application for Characterizing Selective and Other Evolutionary Processes
Steven Weaver et al.
MOLECULAR BIOLOGY AND EVOLUTION (2018)
Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection
Yehuda Z. Cohen et al.
CURRENT OPINION IN HIV AND AIDS (2018)
Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains
Narayanaiah Cheedarla et al.
FRONTIERS IN IMMUNOLOGY (2018)
Tracing HIV-1 strains that imprint broadly neutralizing antibody responses
Roger D. Kouyos et al.
NATURE (2018)
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Elise Landais et al.
RETROVIROLOGY (2018)
Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk
David R. Martinez et al.
JOURNAL OF VIROLOGY (2017)
Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope
Colin Anthony et al.
JOURNAL OF VIROLOGY (2017)
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
Marina Caskey et al.
NATURE MEDICINE (2017)
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies
Mattia Bonsignori et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naive to antiretroviral therapy
Xintao Hu et al.
SCIENTIFIC REPORTS (2017)
Potency of HIV-2-specific antibodies increase in direct association with loss of memory B cells
Cheila Rocha et al.
AIDS (2017)
Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1
Yoshiaki Nishimura et al.
CELL HOST & MICROBE (2017)
Rare HIV-1 Subtype J Genomes and a New H/U/CRF02_AG Recombinant Genome Suggests an Ancient Origin of HIV-1 in Angola
Ines Bartolo et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2016)
HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant
Cassandra A. Simonich et al.
CELL (2016)
On the contribution of Angola to the initial spread of HIV-1
Andrea-Clemencia Pineda-Pena et al.
INFECTION GENETICS AND EVOLUTION (2016)
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Johannes F. Scheid et al.
NATURE (2016)
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 (vol 522, pg 487, 2015)
Marina Caskey et al.
NATURE (2016)
Determinants of HIV-1 broadly neutralizing antibody induction
Peter Rusert et al.
NATURE MEDICINE (2016)
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
Till Schoofs et al.
SCIENCE (2016)
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
Elise Landais et al.
PLOS PATHOGENS (2016)
A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene
Pavel Pugach et al.
JOURNAL OF VIROLOGY (2015)
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey et al.
NATURE (2015)
Antibody responses to envelope glycoproteins in HIV-1 infection
Dennis R. Burton et al.
NATURE IMMUNOLOGY (2015)
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
Jinal N. Bhiman et al.
NATURE MEDICINE (2015)
ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
Tauno Metsalu et al.
NUCLEIC ACIDS RESEARCH (2015)
Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens
Jean-Philippe Julien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
HIV-1 neutralizing antibodies induced by native-like envelope trimers
Rogier W. Sanders et al.
SCIENCE (2015)
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
Peter Hraber et al.
AIDS (2014)
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
Allan deCamp et al.
JOURNAL OF VIROLOGY (2014)
Impact of Clade, Geography, and Age of the Epidemic on HIV-1 Neutralization by Antibodies
Peter Hraber et al.
JOURNAL OF VIROLOGY (2014)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nicole A. Doria-Rose et al.
NATURE (2014)
HIV-1 Specific Antibody Titers and Neutralization among Chronically Infected Patients on Long-Term Suppressive Antiretroviral Therapy (ART): A Cross-Sectional Study
Johannes S. Gach et al.
PLOS ONE (2014)
HIV-1 Diversity, Transmission Dynamics and Primary Drug Resistance in Angola
Ines Bartolo et al.
PLOS ONE (2014)
The early spread and epidemic ignition of HIV-1 in human populations
Nuno R. Faria et al.
SCIENCE (2014)
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2013)
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Hua-Xin Liao et al.
NATURE (2013)
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Rogier W. Sanders et al.
PLOS PATHOGENS (2013)
Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism
Jose M. Marcelino et al.
AIDS (2012)
Broad and Potent Neutralizing Antibody Responses Elicited in Natural HIV-2 Infection
Rui Kong et al.
JOURNAL OF VIROLOGY (2012)
The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection
Elin S. Gray et al.
JOURNAL OF VIROLOGY (2011)
Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals
Georgia D. Tomaras et al.
JOURNAL OF VIROLOGY (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Evolutionary and Structural Features of the C2, V3 and C3 Envelope Regions Underlying the Differences in HIV-1 and HIV-2 Biology and Infection
Helena Barroso et al.
PLOS ONE (2011)
B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy
Susan Moir et al.
BLOOD (2010)
New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0
Stephane Guindon et al.
SYSTEMATIC BIOLOGY (2010)
DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources
Helen V. Firth et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: New insights into the origins of the AIDS pandemic
Ines Bartolo et al.
INFECTION GENETICS AND EVOLUTION (2009)
HIV-1 Genetic Diversity and Transmitted Drug Resistance in Health Care Settings in Maputo, Mozambique
Ines Bartolo et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection
D. Noah Sather et al.
JOURNAL OF VIROLOGY (2009)
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm
Melissa D. Simek et al.
JOURNAL OF VIROLOGY (2009)
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Laura M. Walker et al.
SCIENCE (2009)
Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies
Cecilia Rademeyer et al.
VIROLOGY (2007)
Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients:: Distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections
Shaun K. Rodriguez et al.
JOURNAL OF VIROLOGY (2007)
Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody
FM Brunel et al.
JOURNAL OF VIROLOGY (2006)
Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins:: HIV, SIV, and HCV envelopes and influenza hemagglutinin
M Zhang et al.
GLYCOBIOLOGY (2004)
Share Paper
